Ligand regulation and function of preformed EGFR dimers
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2602436123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Yuhong Zuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520. Hauptthemen laut MEDLINE: ErbB Receptors, Protein Multimerization, Caenorhabditis elegans, Caenorhabditis elegans Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS).
Abstract (Originalsprache)
Receptor tyrosine kinases (RTKs) are key therapeutic targets in cancer, diabetes, and other diseases. With only one transmembrane α-helix—compared with seven in G-protein-coupled receptors—RTKs are thought to be activated by ligand-induced dimerization. Complicating this view, however, one of the best-studied RTKs, the insulin receptor (IR), forms allosterically regulated covalent dimers. Moreover, noncovalent “preformed” dimers have frequently been reported for the sequence-related epidermal growth factor receptor (EGFR), one of the first RTKs for which ligand-induced dimerization was described. Here, we describe a detailed structural view of a preformed EGFR dimer. Using cryo-EM, we describe how the Caenorhabditis elegans EGFR (LET-23) dimerizes without ligand. We show that preformed dimer formation modulates ligand sensitivity in vivo, but is not required for signaling itself. We also elucidate substantial ligand-induced conformational changes in LET-23 required for signaling. Our structures reveal unexpected similarities between regulation of LET-23 and the IR, suggesting that LET-23 may represent an evolutionary “missing link” between the IR and EGFR families. In the absence of ligand, intermolecular interactions within preformed receptor dimers hold the extracellular juxtamembrane regions far apart to separate the intracellular kinase domains so that they remain inactive. Ligand binding disrupts these interactions to remove the restraints on the kinase domains, which then can associate to become activated. Our analysis further suggests a unified model for the allosteric activation of preformed RTK dimers that has important implications for understanding cell-surface EGFR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
- Cancer Biology Institute, Yale University, West Haven, CT 06516.
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.
ORCID-Profile: Yuhong Zuo, Hillel T Schwartz, Kahlil Walker, Long Han, Paul W Sternberg, Kathryn M Ferguson
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- Susan Wojcicki Foundation
- HHS | NIH | National Cancer Institute
Zitieren
APA
Zuo, Y., Schwartz, H. T., Walker, K., Han, L., Sternberg, P. W., & Ferguson, K. M. (2026). Ligand regulation and function of preformed EGFR dimers. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2602436123
Vancouver
Zuo Y, Schwartz HT, Walker K, Han L, Sternberg PW, Ferguson KM. Ligand regulation and function of preformed EGFR dimers. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2602436123
BibTeX
@article{Zuo2026,
author = {Zuo, Yuhong and Schwartz, Hillel T and Walker, Kahlil and Han, Long and Sternberg, Paul W and Ferguson, Kathryn M},
title = {Ligand regulation and function of preformed EGFR dimers},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2602436123}
}
EUVIMED